10 new projects will receive funding for identification, development and commercialisation of biomarker tools and technologies.
Innovate UK is pleased to announce the winners of a funding competition to develop new clinical tools for dementia and neurodegeneration. The focus of the competition is on enhancing clinical trials and precision therapies for dementia patients.
It is a significant step towards advancing dementia research and therapy development, and Innovate UK has awarded over £6 million in funding to 10 innovative organisations through its Small Business Research Initiative (SBRI).
Addressing the global challenge
The number of people in the UK with dementia is estimated at 850,000. It is a complex and diverse disease, posing challenges in identifying effective treatments for patients.
The economic cost associated with the disease is considerable, estimated at £23 billion a year, which is predicted to triple by 2040. This is more than the cost of cancer, heart disease and stroke.
